TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer.

TRIP13 promotes error-prone nonhomologous end joining and induces chemoresistance in head and neck cancer.
复制标题

DOI:
10.1038/ncomms5527
复制
发表时间:
2014-07-31
影响因子:
16.6
通讯作者:
D'Silva, Nisha J.
D'Silva, Nisha J.
中科院分区:
综合性期刊1区
文献类型:
--
作者:
Banerjee, Rajat;Russo, Nickole;Liu, Min;Basrur, Venkatesha;Bellile, Emily;Palanisamy, Nallasivam;Scanlon, Christina S.;van Tubergen, Elizabeth;Inglehart, Ronald C.;Metwally, Tarek;Mani, Ram-Shankar;Yocum, Anastasia;Nyati, Mukesh K.;Castilho, Rogerio M.;Varambally, Sooryanarayana;Chinnaiyan, Arul M.;D'Silva, Nisha J.

文献摘要

参考文献

被引文献

相似文献

头颈部癌(SCCHN)是一种常见的、侵袭性的、难治性的癌症,具有高复发率和死亡率,但难治性的机制仍不清楚。在这里,我们描述了AAA-ATP酶TRIP 13促进治疗抗性的机制。TRIP 13在非恶性细胞中的过表达导致恶性转化。TRIP 13在SCCHN中的高表达导致侵袭性、治疗抗性肿瘤和增强的DNA损伤修复。使用质谱,我们确定介导非同源末端连接(NHEJ)的DNA-PKcs复合物蛋白,作为TRIP 13结合伴侣。使用修复缺陷报告系统,我们表明,TRIP 13促进NHEJ,即使同源重组是完整的。重要的是,TRIP 13的过表达使SCCHN对DNA-PKcs的抑制剂敏感。因此,这项研究定义了SCCHN中治疗耐药性的新机制,并强调了靶向NHEJ以克服SCCHN和可能过度表达TRIP 13的其他癌症治疗失败的重要性。
Head and neck cancer (SCCHN) is a common, aggressive, treatment-resistant cancer with a high recurrence rate and mortality, but the mechanism of treatment-resistance remains unclear. Here we describe a mechanism where the AAA-ATPase TRIP13 promotes treatment-resistance. Overexpression of TRIP13 in non-malignant cells results in malignant transformation. High expression of TRIP13 in SCCHN leads to aggressive, treatment-resistant tumors and enhanced repair of DNA damage. Using mass spectrometry, we identify DNA-PKcs complex proteins that mediate non homologous end joining (NHEJ), as TRIP13 binding partners. Using repair-deficient reporter systems, we show that TRIP13 promotes NHEJ, even when homologous recombination is intact. Importantly, overexpression of TRIP13 sensitizes SCCHN to an inhibitor of DNA-PKcs. Thus, this study defines a new mechanism of treatment resistance in SCCHN and underscores the importance of targeting NHEJ to overcome treatment failure in SCCHN and potentially in other cancers that overexpress TRIP13.
DOI: 10.1038/nmeth1085
发表时间: 2007-10-01
期刊: NATURE METHODS
影响因子: 48
作者:
Fischbach, Claudia;Chen, Ruth;Mooney, David J.
通讯作者: Mooney, David J.
DOI: 10.1038/sj.onc.1206303
发表时间: 2003-03-27
期刊: ONCOGENE
影响因子: 8
作者:
Eymin, B;Leduc, C;Gazzeri, S
通讯作者: Gazzeri, S
DOI: 10.1002/hed.21198
发表时间: 2010-04
影响因子: 2.9
作者:
Brenner, J. Chad;Graham, Martin P.;Kumar, Bhavna;Saunders, Lindsay M.;Kupfer, Robbi;Lyons, Robert H.;Bradford, Carol R.;Carey, Thomas E.
通讯作者: Carey, Thomas E.
DOI: 10.1016/j.molcel.2010.06.026
发表时间: 2010-07-09
期刊: MOLECULAR CELL
影响因子: 16
作者:
Adamo, Adele;Collis, Spencer J.;La Volpe, Adriana
通讯作者: La Volpe, Adriana
DOI: 10.1158/0008-5472.can-03-2144
发表时间: 2004-01-01
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Ginos, MA;Page, GP;Gaffney, PM
通讯作者: Gaffney, PM